Product Details for: Beovu
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravitreal
6MG/0.05ML
Single-Dose Vial
351(a)
Beovu
Rx
002
Injection
Intravitreal
6MG/0.05ML
Pre-Filled Syringe
351(a)
Beovu
Rx
Proper Name
brolucizumab-dbll
brolucizumab-dbll
BLA Number
761125
761125
Applicant
Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation
Original Approval Date
October 7, 2019
October 7, 2019
Date of First Licensure